Please provide your email address to receive an email when new articles are posted on . The FDA announced a new initiative to address safety problems associated with external infusion pumps and is ...
Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. A voluntary safety recall of widely used Alaris infusion ...
Infusion pumps have been plagued with multiple FDA recalls in recent years, and some of the pumps identified in the recalls are still in use, according to a report by DotMed. For example, 200,000 ...
Add Yahoo as a preferred source to see more of our stories on Google. Fresenius Kabi recalled some of its large volume infusion pumps over a software problem that can lead to delays or interruptions ...
An unspecified number of ambulatory infusion pumps were recalled because of nearly 3,700 complaints related to several product issues, the FDA said March 20. InfuTronix voluntarily recalled five types ...
Hospira ($HSP) now faces a Class I recall--the FDA's most serious--because of malfunctioning problems with the company's Symbiq infusion pump system. The designation ...
Baxter ($BAX) is facing a new set of regulator entanglements related to the infusion pumps that were yanked from the market two years ago because manufacturing issues ...
Smiths Medical has been urging healthcare providers to update tens of thousands of its hospital syringe pumps after identifying issues with outdated software, and now the FDA is helping to get the ...
The use of smart pump technology has been proven to reduce the frequency of errors in the administration of intravenous drugs. But software glitches and other potentially dangerous problems persist.
Pump vs control sites had greater vessel density, fibrosis, fibrinogen, and inflammation including eosinophils, insulin-like-growth factor-1 (IGF-1), and transforming growth factor (TGF) β-3, as well ...
You've probably seen an infusion pump, even though the name might make it sound like a mysterious piece of medical technology. These devices govern the flow of IV medications and fluids into patients.
Skin reactions at insulin pump infusion sites are common among people with type 1 diabetes who use the devices and can lead to delivery failure, new research suggests. Insulin pump use is increasingly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results